Biomea Fusion Inc (BMEA)
12.22
-0.56
(-4.38%)
USD |
NASDAQ |
May 17, 16:00
12.22
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Total Assets (Quarterly): 168.49M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 168.49M |
| December 31, 2023 | 199.93M |
| September 30, 2023 | 225.09M |
| June 30, 2023 | 248.67M |
| March 31, 2023 | 112.64M |
| December 31, 2022 | 129.31M |
| September 30, 2022 | 145.05M |
| Date | Value |
|---|---|
| June 30, 2022 | 161.74M |
| March 31, 2022 | 174.86M |
| December 31, 2021 | 185.70M |
| September 30, 2021 | 199.40M |
| June 30, 2021 | 209.53M |
| March 31, 2021 | 59.88M |
| December 31, 2020 | 62.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
59.88M
Minimum
Mar 2021
248.67M
Maximum
Jun 2023
163.06M
Average
171.68M
Median
Total Assets (Quarterly) Benchmarks
| Poseida Therapeutics Inc | 262.58M |
| Cartesian Therapeutics Inc | 325.21M |
| BioXcel Therapeutics Inc | 82.32M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.18M |
| Shareholders Equity (Quarterly) | 135.31M |